Medtronic plc (FRA:2M6)
Germany
· Delayed Price · Currency is EUR | Market Cap | 98.43B |
| Revenue (ttm) | 29.51B |
| Net Income (ttm) | 4.10B |
| Shares Out | n/a |
| EPS (ttm) | 3.18 |
| PE Ratio | 23.99 |
| Forward PE | 15.72 |
| Dividend | 2.60 (3.56%) |
| Ex-Dividend Date | Mar 28, 2025 |
| Volume | 136 |
| Average Volume | 1,154 |
| Open | 72.86 |
| Previous Close | 72.74 |
| Day's Range | 72.86 - 73.02 |
| 52-Week Range | 68.50 - 90.89 |
| Beta | n/a |
| RSI | 58.64 |
| Earnings Date | May 21, 2025 |
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accesso... [Read more]
Financial Performance
In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.
Financial numbers in USD Financial StatementsNews
Caterpillar To Lead Dividend Increases In June As Lowe's Boosted Payout At End Of May
Dividend growth remains robust for select companies, with Casey's, Oil-Dri, and Matson poised for double-digit increases based on strong earnings and expansion. Caterpillar and Kroger are expected to ...
I'm Buying 2 Must-Own Dividend Bargains
The market continues to chase growth while ignoring once beloved income stocks. Verizon offers a compelling 6.3% dividend yield, robust free cash flow, and trades well below its historical valuation, ...
Does This Move Make Medtronic Stock a Buy?
Medtronic plc (MDT) Bernstein's 41st Strategic Decisions Conference - (Transcript)
How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, Abbott
Edwards Lifesciences stock jumped Wednesday after Boston Scientific said it would stop selling its rival heart-valve replacement systems.
Edwards Lifesciences, Medtronic gain as Boston Scientific pulls aortic valve systems
No Rolex For Me - I'm Buying Dividends That Pay For Life
I love luxury watches, but buying more to "earn" access to rarer models made me realize how easy it is to waste capital chasing ego-driven goals. Unlike watches, dividend growth stocks offer reliable ...
Medtronic: Diabetes Spin-Off Is Near-Term Catalyst; Rating Upgrade
Notable healthcare headlines for the week: UnitedHealth, Pfizer and Medtronic in focus
Medtronic chairman and CEO Geoff Martha to speak at Bernstein's Strategic Decisions Conference
GALWAY, Ireland , May 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in Bernstein's 41st Strategic Decisions Conferen...
'WIN-WIN': Medtronic CEO explains the reason for diabetes biz spin
Medtronic chairman and CEO Geoff Martha explains why the company is separating the diabetes business on 'The Claman Countdown.' #foxbusiness #usnews #economy #investing #diabetes #health #markets
Medtronic outlines 5% organic revenue growth target and diabetes business separation ahead of FY26
Medtronic plc (MDT) Q4 2025 Earnings Call Transcript
Tariffs Are Weighing on Medtronic. They Could Lift Costs by Nearly $1 Billion.
Medtronic CEO: More companies are spinning off problems, we're spinning off an attractive asset
Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's spinoff plans, growth strategy and surgical robotics.
Medtronic CEO: More companies are spinning off problems, we're spinning off an attractive asset
Geoff Martha, Medtronic CEO, joins 'Money Movers' to discuss the company's spinoff plans, growth strategy and surgical robotics.
Medtronic to split off its fast-growing diabetes business to unlock its value
The new diabetes company will be predominantly business-to-consumer, while Medtronic's model was more business-to-business.
Medtronic plc 2025 Q4 - Results - Earnings Call Presentation
The following slide deck was published by Medtronic plc in conjunction with their 2025 Q4 earnings call.
Medtronic Dips Despite Quarterly Beat On Plans To Spin Off Diabetes Business
Medtronic stock fell early Wednesday despite beating forecasts after the company said it plans to spin off its diabetes business.
MDT Earnings: A snapshot of Medtronic’s Q4 2025 report
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues for the fourth quarter of 2025, which translated into a sharp increase in net income. The company also […] The post M...
Medtronic Beats Q4 Forecasts, Hikes Dividend, Plans Diabetes Spinoff
Medtronic plc (NYSE: MDT) reported fourth-quarter 2025 sales of $8.93 billion, beating the consensus of $8.82 billion . The medical device maker reported: Adjusted EPS of $1.62, beating the consensus...
Medtronic drops as FY26 outlook trails consensus
Medtronic in charts: Revenue from medical surgical portfolio +0.6%, cardiovascular +6.6% in FQ4
More on Medtronic plc Medtronic: Quite A Few Supportive Sub-Plots Ahead Of The Q4-25 Earnings Medtronic: Time To Buy This Dividend Aristocrat Bargain...